You're reading the free version. Trader adds the live tape and alerts.
Start tracking
PTGX Exercise Disclosure
Waddill William D. · SEC Form 4 · Filed Jun 1, 2026
Exercise
Calculated transaction value
$0
Waddill William D. Director
PTGX
Transaction date
May 29, 2026
Public filing date
Jun 1, 2026
Filing lag
Filed 3 days later
PTGX daily price context
Close on/before transaction
$99.56
May 29, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 9,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001104659-26-069047
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$1M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Protagonist Therapeutics, Inc PTGX | Sale | May 29, 2026 | $896.76K |
| Protagonist Therapeutics, Inc PTGX Current | Exercise | May 29, 2026 | $0 |
| Protagonist Therapeutics, Inc PTGX | Exercise | May 29, 2026 | $106.2K |